A study I did in collaboration with Yale University School of Medicine showed that different pathological types of breast cancer have different survival prognosis, and the article has been published internationally (see below), whereby we can treat different breast cancer patients differently (individualized treatment). This means that certain patients with small ductal cancers can avoid unnecessary overtreatment.